Table 1

Study activities

OutcomesBaseline measurements in each cycle (1 time/cycle)Baseline measurements in each phase of the MC (3 times/cycle)Pre-sessionsPost-sessions24 hours post-sessions48 hours post-sessions72 hours post-sessions
Primary outcomes
 Satisfactionxxxxx
 Visual Analogue Scale for Fatigue (VAS-F)xxxxx
Secondary outcomes
 Abdominal obesity and anthropometric variablesx
 Dietary and nutritional monitoringx
 Monitoring of PA levelsx
 Walking endurance (2-MWT)x
 Physical self-perceptionx
 Catastrophizing Pain Scalex
 Modified Fatigue Impact Scalex
 Multiple Sclerosis Quality of Life-54x
 State anxiety and trait anxietyx
 Body temperaturex
 Bioimpedance analysisx
 Reproductive hormonal profilex
 Inflammatory profilesxx*
 Cognitive profilesxx*
 Neuromuscular strength, voluntary activation and contractile properties: RFD, MVIC, CAR, MULSxxxxx
 Functional assessment: spasticity, gait speed, balance, STS, TUGxxxxx
 Rating of Perceived Exertionxx
 Pain: VAS, algometerxxxxx
 Muscle oxygen saturationDuring sessions
 Lactatexx†
 VO2maxDuring sessions
 Heart rate variability (HRV)During sessions
 Quality of sleep: Karolinska Sleep Diary Questionnaire, actigraphy-based sleep quality, HRVxxx
  • *It will be assessed immediately, at 30 min and 2 hours after the end of the session.

  • †It will be assessed immediately, at 3 min and 30 min after test.

  • CAR, central activation ratio; MC, menstrual cycle; MULS, maximal upper limb strength; MVIC, maximal voluntary isometric strength of the lower limbs; 2-MWT, 2-Minute Walk Test; PA, physical activity; RFD, rate force development; STS, sit-to-stand; TUG, timed up and go test; VO2max, maximal oxygen consumption.